Molecular Diagnostics is the application of molecular biology techniques to study human diseases, using core molecular biology methods such as nucleic acid isolation/quantification, ELISA assays, ... Read More
Molecular Diagnostics is the application of molecular biology techniques to study human diseases, using core molecular biology methods such as nucleic acid isolation/quantification, ELISA assays, in situ hybridization, PCR amplification, and mass spectrometry, among others.Molecular Diagnostic-based tests from Bioactiva catalogcan provide specific information required to identify a range of clinical conditions in infectious diseases, genetic screenings, oncological disorders, and provide help in guiding therapies of specific targets.
For example, Real-time Polymerase Chain Reaction (PCR) kits available at Bioactiva allow for an early and highly specificdiagnosis, thus leading to a fast and selective treatment of the individual patient. Also, Enzyme-Linked Immunosorbent Assays (ELISA) can quantify antibodies, antigens, proteins or glycoproteins in different types of biological probes, human or animal.
Molecular diagnostic kits from Bioactiva are based on the latest research and are performed on the most sophisticated platforms available to the clinical laboratory. Monitoring gene activity with molecular diagnostic assays empowers laboratories to better inform clinical decisions.
Genvinset® MTHFR A1298C is a kit for the in vitro qualitative detection of the A1298C polymorphism (NCBI dbSNP rs1801131; NM_001330358.2:c.1409A>C) in the Methylene tetrahydrofolate reductase (MTHFR) gene (OMIM: 607093) associated with thrombophilia risk in genomic DNA extracted from whole blood using Real Time PCR technology with specific TaqMan® probes.
Adellgene® Fragile X is an in vitro diagnostic kit designed for use in clinical laboratories, which detects the number of CGG triplet repeats (cytosine-guanine-guanine) in the 5’ untranslated region of the gene for fragile X mental retardation (“Fragile X mental retardation-1”: FMR1). It aims to aid diagnosis of the clinical disease associated with Fragile X syndrome, for example, mental retardation, primary ovarian failure, and tremors / ataxia.
Genvinset® HLA B27v5 is an in vitro diagnostic kit for HLA-B*27 group of alleles determination in genomic DNA extracted from whole blood, associated with ankylosing spondylitis predisposition, by real-time PCR using Taqman® probes technology.
Genvinset® HLA CELIAC Plus is an in vitro diagnostic kit for the detection of HLA-DQB1*02, DQB1*03:02, DQA1*05 and DQA1*03 alleles in genomic DNA extracted from whole blood, and the consequent determination of DQ2 and DQ8 antigens associated to celiac disease. The kit is able to determine the homozygosity or heterozygosity status for the DQB1*02 alleles. The analysis is based on real-time PCR technology using TaqMan® probes.
Genvinset® HLA B57v5 is an in vitro diagnostic kit for the determination of the HLA-B*57:01 allele in genomic DNA extracted from whole blood, associated with abacavir hypersensitivity reaction, by real-time PCR using Taqman® probes technology.
Genvinset® PAI-1 4G/5G is a kit for the in vitro qualitative detection of the 4G/5G deletion (NCBI dbSNP rs1799762; NM_000602.5:c.-820G[(4_5)]) in the promoter region of the Plasminogen activator inhibitor 1 (SERPINE1) gene (OMIM: 173360) associated with thrombophilia risk, in genomic DNA extracted from whole blood using Real Time PCR technology with specific TaqMan® probes.
Genvinset® Lactose Intolerance is a semi-automated in vitro diagnostic kit for the qualitative detection of the polymorphisms -13910 C/T (NCBI dbSNP rs4988235; NM_005915.6: c.1917+326C>T) and -22018 G/A (NCBI dbSNP rs182549; NM_005915.5: c.1362+117G>A) of the MCM6 gene (OMIM: 601806) associated with lactase persistence, in genomic DNA extracted from whole blood, by Real Time PCR using specific TaqMan® probes technology.
Genvinset® HLA DQA1*05 is a semi-automated in vitro diagnostic kit for the qualitative detection of the
HLA-DQA1*05 allele in genomic DNA extracted from whole blood, associated with the immunogenicity of
anti-TNF drugs, by Real-Time PCR using TaqMan® probes technology.